Omicron elicits lower antibody responses in individuals with prior COVID-19 infection – Innovita Research

Omicron elicits lower antibody responses in individuals with prior COVID-19 infection

Researchers at Karolinska Institutet and Danderyd Hospital have followed participants who have received three doses of the SARS-CoV-2 vaccine and compared their immune responses after Omicron infection. The results, which are published in The Lancet Infectious Diseases, show that Omicron infection elicits significantly higher antibody responses in individuals without prior COVID-19 infection as compared to previously infected individuals.

COVID-19’s hard-to-predict effects likely owe in part to genetic differences. A Penn-led study analyzing the genomes of a diverse set of populations globally points to genetic variants that may help explain some of the variability in disease severity.

Image credit: MintBlack4u via Pixabay, free license

On the contrary, previous research on infection with other SARS-CoV-2 variants has shown that the combination of infection and vaccination, referred to as hybrid immunity, elicits stronger immune responses than infection-induced or vaccine-induced immune responses alone.

Crucial knowledge gaps

“Interestingly, antibody responses were stronger in participants without prior SARS-CoV-2 infection, who encountered the virus for the first time, despite similar symptoms and viral load,” says Charlotte Thålin, a researcher at the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet and consultant in internal medicine at Danderyd Hospital. “The mechanisms behind this are not clear, but our findings imply that there are crucial gaps in our current understanding of the impact of prior infection on immune responses following reinfection. We will next investigate immune responses in airway mucosa, perhaps mucosal antibody responses give a different picture.”

Charlotte Thålin is the principal investigator of the COMMUNITY study on which the results are based. The current sub-study included 56 participants, of which 16 had been diagnosed with COVID-19 before they were infected with the Omicron variant. None of the Omicron infected participants became severely ill, and prior infection did not affect symptoms and viral load.

Blood samples were regularly collected

Following infection, blood samples were regularly collected from the participants and analyzed for antibody titers against the SARS-CoV-2 wild type and Omicron variant. The results showed that antibody titers increased 2-3 weeks after Omicron infection and were significantly higher in participants without prior COVID-19 infection than previously infected individuals.

“At present, large populations are subject to frequent encounters with the SARS-CoV-2 antigen through repeated vaccine doses and infections with various SARS-CoV-2 variants,” says Sebastian Havervall, Ph.D. student at the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet and consultant in internal medicine at Danderyd Hospital. “Effects on the immune system of these repeated encounters are unknown and important to follow.”

Source: Karolinska Institutet